PKO Investment Management Joint Stock Co Purchases 11,400 Shares of Corteva, Inc. $CTVA

PKO Investment Management Joint Stock Co raised its position in Corteva, Inc. (NYSE:CTVA) by 58.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,898 shares of the company’s stock after buying an additional 11,400 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in Corteva were worth $2,586,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Annis Gardner Whiting Capital Advisors LLC grew its stake in shares of Corteva by 9.1% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock valued at $112,000 after acquiring an additional 140 shares in the last quarter. Drive Wealth Management LLC increased its position in Corteva by 3.8% during the fourth quarter. Drive Wealth Management LLC now owns 4,259 shares of the company’s stock worth $285,000 after acquiring an additional 156 shares during the period. Reynders McVeigh Capital Management LLC raised its stake in Corteva by 2.9% in the 4th quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company’s stock worth $381,000 after purchasing an additional 160 shares in the last quarter. Chesapeake Capital Corp IL boosted its holdings in Corteva by 0.9% in the 4th quarter. Chesapeake Capital Corp IL now owns 18,035 shares of the company’s stock valued at $1,209,000 after purchasing an additional 161 shares during the period. Finally, Fox Run Management L.L.C. boosted its holdings in Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after purchasing an additional 164 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE CTVA opened at $78.85 on Tuesday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The firm has a market capitalization of $52.74 billion, a price-to-earnings ratio of 46.38, a P/E/G ratio of 2.40 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm’s 50 day simple moving average is $79.54 and its 200 day simple moving average is $75.85.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CTVA. Argus raised their target price on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Oppenheimer increased their price target on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Mizuho raised their price objective on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Morgan Stanley lifted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Finally, Jefferies Financial Group increased their target price on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $88.81.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.